全文获取类型
收费全文 | 36600篇 |
免费 | 3563篇 |
国内免费 | 1547篇 |
专业分类
耳鼻咽喉 | 438篇 |
儿科学 | 633篇 |
妇产科学 | 501篇 |
基础医学 | 9528篇 |
口腔科学 | 1019篇 |
临床医学 | 2295篇 |
内科学 | 5838篇 |
皮肤病学 | 632篇 |
神经病学 | 1785篇 |
特种医学 | 651篇 |
外国民族医学 | 1篇 |
外科学 | 3614篇 |
综合类 | 4684篇 |
现状与发展 | 9篇 |
预防医学 | 2141篇 |
眼科学 | 454篇 |
药学 | 2769篇 |
5篇 | |
中国医学 | 1106篇 |
肿瘤学 | 3607篇 |
出版年
2024年 | 54篇 |
2023年 | 420篇 |
2022年 | 836篇 |
2021年 | 1242篇 |
2020年 | 921篇 |
2019年 | 784篇 |
2018年 | 966篇 |
2017年 | 1082篇 |
2016年 | 1322篇 |
2015年 | 1507篇 |
2014年 | 2090篇 |
2013年 | 2471篇 |
2012年 | 2106篇 |
2011年 | 2391篇 |
2010年 | 1999篇 |
2009年 | 2084篇 |
2008年 | 2081篇 |
2007年 | 2146篇 |
2006年 | 1988篇 |
2005年 | 1762篇 |
2004年 | 1498篇 |
2003年 | 1311篇 |
2002年 | 1051篇 |
2001年 | 956篇 |
2000年 | 797篇 |
1999年 | 701篇 |
1998年 | 538篇 |
1997年 | 481篇 |
1996年 | 420篇 |
1995年 | 393篇 |
1994年 | 386篇 |
1993年 | 335篇 |
1992年 | 286篇 |
1991年 | 233篇 |
1990年 | 214篇 |
1989年 | 225篇 |
1988年 | 202篇 |
1987年 | 172篇 |
1986年 | 133篇 |
1985年 | 156篇 |
1984年 | 157篇 |
1983年 | 86篇 |
1982年 | 132篇 |
1981年 | 112篇 |
1980年 | 105篇 |
1979年 | 82篇 |
1978年 | 64篇 |
1977年 | 47篇 |
1976年 | 55篇 |
1973年 | 25篇 |
排序方式: 共有10000条查询结果,搜索用时 265 毫秒
151.
大鼠骨髓间质干细胞体外分离培养及生物学特性研究 总被引:6,自引:5,他引:1
目的:建立大鼠骨髓间质干细胞(mesenchymal stem cells,MSCs)体外分离培养方法,并对大鼠MSCs的生物学特性进行研究。方法:分离5~8周龄的大鼠股骨骨髓进行体外培养,取5代以后的MSCs观察形态特征,绘制生长曲线,进行细胞化学染色,并用流式细胞仪检测其表面标志和进行细胞周期分析。结果:大鼠MSCs细胞形态呈长梭形或多边形,细胞生长曲线呈S形,群体倍增时间为30h,细胞化学染色显示碱性磷酸酶(ALP)、过氧化物酶(POX)、苏丹黑B(SB)阴性,而*醋酸萘酚醋酶(α-NAE)与糖原(PAS)阳性,流式细胞仪检测结果显示CD29、CD44、CD90表达阳性,而CD34、CD38、CD45表达阴性;细胞周期分析显示,G0/G1期:79.48%,G2/M期:6.10%,S期:14.42%。结论:本方法分离纯化出的是MSCs,其在体外具有生长稳定,增殖较快的特点,是组织工程研究中良好的细胞来源,也是转基因研究优良的载体细胞。 相似文献
152.
复方肾华治疗大鼠改良慢性血清病肾炎的实验研究 总被引:2,自引:0,他引:2
目的 观察复方肾华胶囊对改良大鼠慢性血清病肾炎模型的治疗作用。方法 采取传统大鼠慢性血清病肾炎模型制作方法加上切除大鼠一侧肾脏、隔日饮饲牛血清白蛋白 (BSA)酸化水、腹腔注射大肠杆菌内毒素 (LPS)等措施 ,制作肾炎模型 ,与西药蒙诺作对照 ,观察中药肾华对肾炎大鼠尿蛋白、血生化、凝血指标、肾功能、病理、免疫荧光以及增殖细胞核抗原 (PCNA)表达的作用。结果 肾华胶囊能够显著减轻肾炎大鼠肾脏重量及肾重指数、降低肾炎大鼠尿蛋白、升高血清蛋白、降低胆固醇、甘油三酯、改善肾功能、纠正凝血功能紊乱、减轻肾脏病理改变、减轻免疫荧光变化、减弱PCNA的表达。结论 中药肾华胶囊对大鼠慢性血清病肾炎模型有较好的治疗作用 相似文献
153.
154.
Hiromitsu Matsuzaki Hiroyuki Hata Norio Asou Minoru Yoshida Fumihiko Matsuno Motohiro Takeya Kazunari Yamaguchi Isao Sanada Kiyoshi Takatsuki 《Cancer science》1992,83(5):450-457
A stable cell line, KHM-3S, was established from a patient with small cell lung cancer (SCLC), who had a high serum level of soluble interleukin 2 receptors (sIL2-R) and was seropositive for human T cell leukemia virus (HTLV)-l. KHM-3S cells were positive for IL2-R (Tac) and NKH-1, but negative for other lymphocytic markers such as OKT 11, OKT 4, OKT 8, T cell receptor (WT 31), B 1, and B 4. Moreover, the KHM-3S cells were negative for leukocyte common antigen and strongly positive for neuron-specific enolase (NSE). Secretion of sIL2-R and NSE by the KHM-3S line was detected by an enzyme-linked immunosorbent assay. Rearrangement of the T cell receptor gene and monoclonal HTLV-1 integration were found by Southern blot analysis of KHM-3S DNA. However, Northern blot analysis showed no T cell receptor mRNA. KHM-3S may be useful for studies on the role of HTLV-1 in carcinogenesis and IL2-R expression in SCLC. 相似文献
155.
RHAMM (Receptor for Hyaluronic Acid Mediated Motility) has been identified as a receptor for the extracellular matrix component hyaluronan (HA) and was recently shown to be essential for the locomotion of normal and transformed peripheral cells. Until now the potential role of RHAMM in the motility of neural-derived cells has not been investigated. Here, we report that cultured primary astrocytes, astrocyte cell lines, and microglia express this receptor and exhibit RHAMM-dependent motility. Immunocytochemical localization of RHAMM showed that it was often present as aggregates at the periphery of cells in contact with one another or concentrated on protruding processes of isolated cells. Glial cells contained 50 and 72 kDa forms of RHAMM, and both of these forms were found to have HA binding capacity. Time lapse imaging of cell locomotion revealed a significant inhibition of motility and process elongation by neutralizing anti-RHAMM antibodies and by peptides corresponding to the HA binding domains of RHAMM. These results demonstrate that RHAMM serves a role in glial cell locomotion in vitro and provide the basis for investigations of the motile behavior of glial cells in vivo after CNS injury. 相似文献
156.
A. Gautam S.A. Fischer A.F. Yango R.Y. Gohh P.E. Morrissey A.P. Monaco 《International immunopharmacology》2006,6(13-14):2023
Cell mediated immunity (CMI) was assessed by the ImmuKnow assay in 12 patients after kidney transplantation, who presented with viral infection. Treatment included lowering of immunosuppression in all cases and antiviral treatment if indicated. The assay was repeated during the follow up. The ImmuKnow assay at time of presentation of viral infections was 56.8 ± 58.2 (range 3–178; median 22) ATP ng/ml. With the clearance of viral infection and lowering of immunosuppression, the assay showed an increase in the level of CMI at 194.5 ± 118.9 (range 53–409; median 150) ATP ng/ml. There was viral clearance or stabilization in all cases and there was no incidence of allograft rejection. The ImmuKnow assay of CMI can be used to titrate initial immunosuppression reduction and its subsequent increase, in patients with viral infection after transplantation. 相似文献
157.
A. Pascher S. Proesch J. Pratschke A. Reutzel-Selke B. Sawitzki M. Lehmann S. G. Tullius P. Neuhaus H.-D. Volk P. Reinke 《American journal of transplantation》2006,6(9):2035-2045
In order to assess the role of heterologous immunity on tolerance induction (TI) by signal 1 modification, the influence of rat cytomegalovirus infection (RCMVI) on TI by a non-depleting monoclonal anti-CD4 mAb (monoclonal antibody) (RIB 5/2) in a rat kidney transplant (KTx) model was investigated. Orthotopic rat KTx (Dark Agouty (DA)-->Lewis (LEW)) was performed after TI with RIB 5/2 [10 mg/kg body weight (BW); day -1, 0, 1, 2, 3; i.p. (intraperitoneal route)]. RCMVI (5x10E5 Plaque forming units [PFU] i.p.) was simultaneously conducted to KTx, 50 days after KTx, and 14 days before and after KTx. RIB 5/2 induced robust allograft tolerance even across the high-responder strain barrier. RCMVI broke RIB 5/2-induced tolerance regardless of the time of RCMVI but did not induce acute graft failure during the 120 days follow-up. RCMVI induced a significant chronic deterioration of allograft function (p<0.01) and enhanced morphological signs of chronic allograft damage (p<0.05). Cellular infiltrates and major histo-compatibility complex (MHC)-expression were more pronounced (p<0.05) in the infected groups. RCMVI induced not only RCMV-specific T-cell response but also enhanced the frequency of alloreactive T cells. RCMV interferes with anti-CD4 mAb-induced tolerance and leads to chronic allograft damage. The data we presented suggest a potentially important role of viral infections and their prophylaxis in clinical TI protocols. 相似文献
158.
L. Valinsky S. Simhoni R. Bassal V. Agmon R. Yishai M. S. Green D. Cohen 《Clinical microbiology and infection》2006,12(10):968-973
A seroepidemiological study was performed to evaluate immunity to diphtheria and to determine the correlates of diphtheria toxoid antibody levels among children and adults in Israel. In total, 3,185 sera from an age-stratified sample of children and adults, obtained in 2000-2001, were tested for diphtheria toxoid antibodies by an in-house double-antigen ELISA. A level of or=0.1 IU/mL (full protection or seropositivity). Seronegativity increased significantly in subjects aged >50 years, reaching levels of 9.7%, 12.6% and 18.9% in the groups aged 50-54, 55-59 and >60 years, respectively (p 0.001), with rates of basic immunity following a similar pattern. Subjects born abroad had higher seronegativity rates than those born in Israel (7.7% vs. 4.9%; p 0.019). No difference in diphtheria toxoid antibody levels was found according to other demographical variables, such as gender, Jewish or Arab ethnicity, urban or rural settlements, and the subjects' place of residence. The level of immunity to diphtheria among children and adults in Israel was satisfactory, with the exception of individuals aged >50 years. The risk of diphtheria outbreaks is low, but sporadic cases may occur among individuals lacking basic immunity against the disease. 相似文献
159.
毛囊细胞移植诱导裸鼠毛囊样结构形成的研究 总被引:6,自引:1,他引:5
目的:观察毛囊细胞移植诱导裸鼠毛发再生和毛囊重建情况.方法:采用细胞培养技术和裸鼠移植技术,将培养的毛囊毛乳头细胞、真皮鞘细胞和头皮真皮成纤维细胞按比例与毛囊上皮细胞混合,移植到裸鼠皮下,观察毛囊形成情况.结果:在毛囊毛乳头细胞与毛囊上皮细胞混合后移植到裸鼠皮下后可见毛囊样结构形成,而毛囊真皮鞘细胞和头皮成纤维细胞与毛囊上皮细胞混合则不能诱导裸鼠毛囊样结构形成.结论:低传代培养的毛乳头细胞与毛囊上皮细胞混合后在体内可诱导毛囊样结构形成. 相似文献
160.
放射线照射对体外培养的骨巨细胞瘤细胞作用的实验研究 总被引:1,自引:0,他引:1
目的 :对体外培养的骨巨细胞瘤细胞进行放射线照射 ,并观察其效应。方法 :对 6例经临床、X线和病理组织学检查证实的骨巨细胞瘤标本进行体外细胞培养 ,传代后实验组进行放射线照射处理 ,对照组未进行放射线处理。分别采用倒置显微镜观察、台盼蓝染色后计数、MTT法测定和FCM分析来观察放射线照射对体外培养的骨巨细胞瘤细胞的细胞毒性和细胞周期的影响。结果 :放射线照射后 ,体外培养的骨巨细胞瘤细胞可见逐渐发生皱缩和脱落 ,细胞存活率为 8 2 7%~ 13 5 0 % ,细胞毒性指数为 83 19% ,FCM分析显示G0与G1期比例明显增加 ,G2与M期比例明显减少。结论 :放射线照射对体外培养的骨巨细胞瘤细胞有较强的细胞毒性作用 相似文献